Look for us at #AAIC24 where we're discussing the role of cognitive assessments in #AlzheimersResearch and sharing interesting findings in these posters: 🌍 Geo-cultural Variation in MMSE Score Changes in Alzheimer's Trials 📊 MMSE and CDR Score Changes in Multinational Alzheimer's Trials 📑 Impact of Rater Change on MMSE Data: A Post-Hoc Analysis 📉 Impact of Site Size on Data Quality in Early Alzheimer's Disease Clinical Trials Meet our experts and get resources: https://hubs.li/Q02GLX_S0
Signant Health
Pharmaceutical Manufacturing
Blue Bell, Pennsylvania 109,894 followers
The Evidence Generation Company
About us
Signant Health is the evidence generation company. We are focused on leveraging software, deep therapeutic and scientific knowledge, and operational expertise to consistently capture, aggregate, and reveal quality evidence for clinical studies across traditional, virtual, and hybrid trial models. For more than 25 years, over 600 sponsors and CROs of all sizes – including all Top 20 pharma – have trusted Signant solutions for remote and site-based eCOA, EDC, eConsent, RTSM, supply chain management, and data quality analytics. Learn more at www.signanthealth.com.
- Website
-
http://www.signanthealth.com
External link for Signant Health
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Blue Bell, Pennsylvania
- Type
- Privately Held
- Specialties
- clinical trial software, eCOA, eConsent, IRT, Clinical Supply Optimization, Patient Engagement, Rater Training, Data Quality, Analytics, Scientific Consulting, and Clinical Consulting
Locations
Employees at Signant Health
-
John Hughes
Business Development and Operations Executive - enabling revenue growth through strategy, process, technology and culture.
-
Markku Lukkarinen
Senior UX Designer at Weasel Software
-
Joanne Kondan
Finance and Operations Leader, Specializing in Operational Effectiveness
-
Konstantin Kondakov
SRE / CloudOps / DevOps / TechOps / WebOps "hands-on"senior manager
Updates
-
Signant is pleased to announce the appointment of industry veteran Paul Richmond to chief commercial officer. Read how Paul will help guide our biotech, pharma, and CRO customers with selecting the right #eClinical solutions for their trials: https://hubs.li/Q02Gy7h80
-
-
In this perspective paper, Signant's Bill Byrom and industry colleagues explore opportunities, challenges, and strategies for leveraging sensor-based functional outcomes (SFBO) in #clinicaltrials. Explore their strategies and insights for optimizing evidence generation using SFBOs alongside other COAs: https://hubs.li/Q02G0nkP0 #digitalhealth
-
In our latest blog, Maria Visser and Martina Micaletto discuss the subjectivity of instruments used to measure #atopicdermatitis severity, the importance of data accuracy, and how different assessment methods can impact trial outcomes. Read more: https://hubs.li/Q02FPf490 #ClinicalTrials #DermatologyResearch
A closer look at key assessment methods and their impact on outcomes
https://www.signanthealth.com
-
Discover a simpler #clinicaltrial experience without compromising quality or functionality with Signant SmartSignals® Unified Platform. Say goodbye to managing multiple systems and vendors for each trial. Learn more: https://hubs.li/Q02Ffn7m0
See what sponsors and CROs have been asking for
https://www.signanthealth.com
-
In this podcast, Signant's Bill Byrom PhD, speaks with Julian Minett, CEO of Spencer Group, about the use of #AI and #MachineLearning in clinical #drugdevelopment. While covering a breadth of topics and application areas, one promising area they examine is how AI can be a useful tool in COA development and implementation, using case study illustrations. Listen now: https://hubs.li/Q02F3kVd0
The Future of eCOA & AI with Signant Health’s Bill Byrom - Spencer Group
https://spencergroup.com
-
At #AAIC2024, discover how our renowned #alzheimers experts and proven endpoint quality solutions continue to facilitate success in #clinicaltrials. Meet our team and get resources: https://hubs.li/Q02F0wLF0 Dawie Wessels, Maria Kerwin, Linda Berkowitz, Sandra Marticio, JENNIFER BETZ, Matthew Cordaro, MBA, Brian Mcallister, Alex Brooks, david miller
Pioneering Alzheimer's trial solutions to support research breakthroughs
hub.signanthealth.com
-
Navigating the complexities of #RTSM can be challenging for sponsors and service providers. Our latest blog post by James Stringer highlights best practices and common pitfalls to help you optimize your #clinicaltrials. Learn more: https://hubs.li/Q02DYJ3b0
Drive continuous improvement, ensure optimal outcomes for every study
https://www.signanthealth.com
-
Calling all CROs: Looking to stay competitive and win more business? 📈 You won't want to miss insights from our latest eBook. Discover how #eClinical partnerships can help you differentiate and deliver successful trials for sponsors. Get your copy now: https://hubs.ly/Q02DpBhd0
Gain insights and practical strategies developed by industry experts
discover.signanthealth.com
-
🚀Seeking a faster #eCOA solution? Discover TrialMax® – the industry's most reliable and feature-rich platform, now enhanced with intelligent automations for 33% faster study launches. Learn more: https://hubs.li/Q02DcdhZ0